Vogt–Koyanagi–Harada disease-like uveitis following nivolumab administration treated with steroid pulse therapy: a case report

Vogt–Koyanagi–Harada disease-like uveitis following nivolumab administration treated with steroid pulse therapy: a case report

Abstract Background Immune checkpoint inhibitors can cause various adverse effects. Recently it has been shown that Vogt–Koyanagi–Harada (VKH) disease-like uveitis can occur in patients treated with nivolumab. Case presentation A 69-year-old man developed bilateral panuveitis after nivolumab treatme...

Full description

Bibliographic Details
Main Authors: Ryo Kikuchi, Tatsukata Kawagoe, Kazuki Hotta
Format: Article
Language:English
Published: BMC 2020-06-01
Series:BMC Ophthalmology
Subjects:
Immune checkpoint inhibitors
PD-1 inhibitor
Nivolumab
Immune related adverse events
Vogt–Koyanagi–Harada disease
HLA-DR4
Online Access:http://link.springer.com/article/10.1186/s12886-020-01519-5

Internet

http://link.springer.com/article/10.1186/s12886-020-01519-5

Similar Items